Technical Field
The present disclosure generally relates to catheter assemblies. More particularly, the present disclosure relates to a catheter assembly including one or more sealing members for facilitating the fluid interconnection between two or more surfaces of the catheter assembly.
Description of the Related Art
Catheters are flexible medical instruments which facilitate the withdrawal and introduction of fluids from and to body cavities, ducts, and vessels. Catheters may have particular application in a hemodialysis procedure where blood is withdrawn from a blood vessel for treatment, and subsequently returned to the blood vessel for circulation. Known hemodialysis catheter assemblies include multiple lumen catheters, such as dual lumen or triple-lumen catheters, which permit bi-directional fluid flow within the catheter whereby one lumen is dedicated for withdrawal of blood from a vessel and the other lumen is dedicated for return of treated blood to the vessel. During an exemplary hemodialysis procedure, a multiple lumen catheter is inserted into a body and blood is withdrawn through an arterial lumen of the catheter. The removed blood is directed to a hemodialysis machine, via extension tubes, which dialyzes, or purifies, the blood to remove waste and toxins. The dialyzed blood is returned to the patient through a venous lumen of the catheter. One example of such a catheter is described in U.S. patent application Ser. No. 12/041,563 filed on Mar. 3, 2008, now U.S. Pat. No. 7,731,708, the entire contents of which are incorporated herein by this reference.
Typically, a multiple lumen catheter assembly includes a flexible multiple lumen catheter which is connected to a distal side of a more rigid hub assembly and an extension tube assembly which is connected to a proximal side of the hub assembly and is adapted to communicate with a medical device, such as a hemodialysis machine. The connection between the hub assembly and the catheter lumens may be effected by providing a close geometric fit between lumens of the catheter and hub extensions. Such a tight geometric fit may not always provide a fluid tight seal.
Consequently, it would be desirable to provide an improved seal between the rigid hub assembly and catheter of a catheter assembly as well as between other interconnected components of medical devices.
In general, in one aspect of the present disclosure, a catheter assembly includes a catheter, a hub, and a sealing member. At least a portion of one or both of the catheter and the hub may include a rigid material and at least a portion of one or both of the catheter and the hub may include an elastomeric material. The catheter defines one or more lumens. The hub includes one or more hub extensions dimensioned to be received within the one or more lumens of the catheter. The hub may further include a casing. The casing defines a cavity configured and dimensioned to accommodate the sealing member. The sealing member is positioned adjacent the interface of the catheter and the hub. The sealing member may include a bioactive agent. The sealing member includes an expandable material which increases in volume upon exposure to moisture. The expandable material may expand to a volume sized to improve the seal at the interface. The expandable material may include a hydrophilic polymer and/or a hydrophilic gel.
The one or more hub extensions define a first connector surface and the catheter defines a second connector surface. The first and second connector surfaces form a tight geometric fit when the one or more hub extensions are received within the one or more lumens of the catheter. The sealing member may be coated on at least a portion of one or both of the first and second connector surfaces.
In embodiments, the sealing member may define a sleeve. The sleeve is positionable on at least a portion of one or both of the first and second connection surfaces. One or more of the catheter, the one or more hub extensions, and the sleeve may define two or more lumens. The sleeve is dimensioned to accommodate one or more of the two or more lumens of one or both of the catheter and the one or more hub extensions. One or more of the lumens of the catheter, the one or more hub extensions, and the sleeve may be substantially D-shaped.
Various embodiments of the presently disclosed catheter assemblies including improved sealing features are described herein with references to the accompanying drawings, wherein:
In the discussion that follows, the term “proximal” or “trailing” will refer to the portion of a structure that is closer to a clinician, while the term “distal” or “leading” will refer to the portion of a structure that is farther from the clinician. As used herein, the term “subject” refers to a human patient or other animal. The term “clinician” refers to a doctor, nurse or other care provider and may include support personnel.
The catheter 50 defines one or more lumens. In embodiments, the catheter 50 defines two adjacent substantially D-shaped lumens 52A, 52B. The lumens 52A, 52B of the catheter 50 have complimentary mating surfaces with the D-shaped hub extensions 22, 24. As illustrated, distal ends 22D, 24D of the hub extensions 22, 24 may be positioned within lumens 52A, 52B of catheter 50. The one or more hub extensions 22, 24 are dimensioned to be received within the one or more lumens 52A, 52B of the catheter 50 and define one or more first connector surfaces 26. The catheter 50 defines one or more second connector surfaces 54 that engage first connector surfaces 26 in a close geometric fit when the one or more hub extensions 22, 24 are received within the one or more lumens 52A, 52B of the catheter 50. In this manner, hub assembly 20 fluidly couples first and second extension tubes 30, 40 with catheter 50. Alternately, the catheter lumens and hub extensions may have a variety of different configurations.
With continued reference to
Referring now to
The sealing member 100 may be coated and/or chemically bonded to the external surface of at least a portion of the hub extensions 22, 24 relative to the one or more first connector surfaces 26. As illustrated in
With reference to
As shown in
As illustrated in
In order to prevent undesirable biological growth, the sealing members or an internal surface of the catheter may have medicinal agents or bioactive agents impregnated and/or coated thereon.
Medicinal agents that may be incorporated into or provided on the disclosed sealing members or on an internal surface of the catheter include antimicrobial agents, anti-virals, anti-fungals, and the like. Antimicrobial agents as used herein is defined by an agent which by itself or through assisting the body (immune system) helps the body destroy or resist microorganisms which may be pathogenic (disease causing). The term “antimicrobial agent” includes antibiotics, quorum sensing blockers, surfactants, metal ions, antimicrobial proteins and peptides, antimicrobial polysaccharides, antiseptics, disinfectants, anti-virals, anti-fungals, and combinations thereof.
While several embodiments of the disclosure have been shown in the drawings and/or discussed herein, it is not intended that the disclosure be limited thereto, as it is intended that the disclosure be as broad in scope as the art will allow and that the specification be read likewise. Therefore, the above description should not be construed as limiting, but merely as exemplifications of particular embodiments. Those skilled in the art will envision other modifications within the scope and spirit of the claims appended hereto.
Number | Name | Date | Kind |
---|---|---|---|
4214779 | Losell | Jul 1980 | A |
4674496 | Svadjian et al. | Jun 1987 | A |
5059170 | Cameron | Oct 1991 | A |
5129891 | Young | Jul 1992 | A |
5279597 | Dassa et al. | Jan 1994 | A |
5401245 | Haining | Mar 1995 | A |
5505714 | Dassa et al. | Apr 1996 | A |
5636875 | Wasser | Jun 1997 | A |
6099519 | Olsen et al. | Aug 2000 | A |
6113572 | Gailey et al. | Sep 2000 | A |
6423053 | Lee | Jul 2002 | B1 |
6638242 | Wilson et al. | Oct 2003 | B2 |
6872198 | Wilson et al. | Mar 2005 | B1 |
6916051 | Fisher | Jul 2005 | B2 |
6921396 | Wilson et al. | Jul 2005 | B1 |
6969381 | Voorhees | Nov 2005 | B2 |
7163531 | Seese | Jan 2007 | B2 |
7300430 | Wilson et al. | Nov 2007 | B2 |
7310544 | Brister | Dec 2007 | B2 |
7377915 | Rasmussen et al. | May 2008 | B2 |
20030153898 | Schon | Aug 2003 | A1 |
20040065333 | Wilson et al. | Apr 2004 | A1 |
20040167478 | Mooney et al. | Aug 2004 | A1 |
20050107770 | Schweikert et al. | May 2005 | A1 |
20050261665 | Voorhees | Nov 2005 | A1 |
20050267400 | Haarala et al. | Dec 2005 | A1 |
20060015086 | Rasmussen et al. | Jan 2006 | A1 |
20060189961 | Miyahara | Aug 2006 | A1 |
20060276773 | Wilson | Dec 2006 | A1 |
20070016167 | Smith | Jan 2007 | A1 |
20070060866 | Raulerson et al. | Mar 2007 | A1 |
20070196414 | Hammarsten | Aug 2007 | A1 |
20080147012 | Rome | Jun 2008 | A1 |
20080214991 | Haarala | Sep 2008 | A1 |
20090054845 | Puhasmagi | Feb 2009 | A1 |
20100010445 | Powers | Jan 2010 | A1 |
20100137778 | Kunjan | Jun 2010 | A1 |
20100204635 | Haarala | Aug 2010 | A1 |
20120083750 | Sansoucy | Apr 2012 | A1 |
Number | Date | Country |
---|---|---|
2003000116 | Jan 2003 | WO |
WO 03033049 | Apr 2003 | WO |
WO 2004108183 | Dec 2004 | WO |
WO 2009129352 | Oct 2009 | WO |
Entry |
---|
European Search Report corresponding to European Patent Application No. 11 18 3053.5, dated Nov. 18, 2011; 5 pages. |
First Office Action issued in the corresponding Chinese Application No. 201110348244.5 dated Apr. 15, 2013. |
Third Office Action issued in Chinese Application No. 201110348244.5 dated Jun. 27, 2014. |
European Examination Report from Application No. EP 11183053.5 dated Jun. 13, 2014. |
Number | Date | Country | |
---|---|---|---|
20120083766 A1 | Apr 2012 | US |